| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 01/24/2002 | CA2377666A1 Stem cell reinforcing material |
| 01/23/2002 | EP1174431A2 2-Phenyl-substituited Imidazotriazinones as Phoshodiesterase Inhibitors |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173484A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 01/23/2002 | EP1173443A1 Cyclic urea and cyclic amide derivatives |
| 01/23/2002 | EP1173440A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 01/23/2002 | EP1173433A1 Cyanopyrroles as progesterone receptor agonists |
| 01/23/2002 | EP1173426A1 Cyclocarbamate derivatives as progesterone receptor modulators |
| 01/23/2002 | EP1173423A1 Benzimidazolones and analogues and their use as progesterone receptor ligands |
| 01/23/2002 | EP1173253A1 Contraceptive compositions containing cyclic carbamates and amide derivatives |
| 01/23/2002 | EP1173252A1 Products and methods for brachytherapy |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP1173213A1 Compositions containing benzimidazolones and progestogens |
| 01/23/2002 | EP1173212A1 Contraceptive compositions contaning indolone derivatives and progestational agents |
| 01/23/2002 | EP1173211A1 Contraceptive compositions containing 3,3-substituted indoline derivatives and uses thereof |
| 01/23/2002 | EP1173210A1 Contraceptive compositions containing antiprogestinic and progestinic |
| 01/23/2002 | EP1173209A1 Contraceptive compositions containing 2,1-benzisothiazoline 2,2-dioxides and progestationals |
| 01/23/2002 | EP1173208A2 Contraceptive compositions containing cyclic urea and amide derivatives |
| 01/23/2002 | EP1173206A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives |
| 01/23/2002 | EP1173183A2 Use of compounds with a nitrogen-oxygen heterocycle |
| 01/23/2002 | EP1173181A2 Compositions comprising phosphodiesterase inhibitors for the treatment of sexual disfunction |
| 01/23/2002 | EP1173178A1 Apomorphine and sildenafil composition |
| 01/23/2002 | EP1173167A1 Treatment of female arousal disorder |
| 01/23/2002 | EP1173160A1 (e)-styryl sulfone anticancer agents |
| 01/23/2002 | EP1173155A1 Gum pad for delivery of medication to mucosal tissues |
| 01/23/2002 | EP1090028B1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 01/23/2002 | EP1025100B1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 01/23/2002 | EP0854711B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 01/23/2002 | CN1332744A Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 01/23/2002 | CN1332741A Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 01/23/2002 | CN1332740A 5HT antagonists for antidepressant therapy |
| 01/23/2002 | CN1332727A 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/23/2002 | CN1332628A Method of treating sexual disturbances |
| 01/23/2002 | CN1332012A Chinese medicine fumigant for treating vulval disease and its prepn |
| 01/23/2002 | CN1331973A Prepn. of prostaglandin E1 urethra suppository |
| 01/23/2002 | CN1078078C Traditional Chinese medicinal preparation for curing endometriosis |
| 01/22/2002 | US6340703 Treatment or prevention of osteoporosis |
| 01/22/2002 | US6340694 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 01/22/2002 | US6340688 Administering to female during menstrual cycle amount of competitive progesterone antagonist which is less than ovulation-inhibiting dose and less than abortion-inductive dose |
| 01/22/2002 | US6340686 Gonadotropin-releasing hormone antagonists |
| 01/22/2002 | US6340678 4,4-difluoro-2,3,4,5-tetrahydro-1H-1-benzoazepine derivatives and drug compositions containing them |
| 01/22/2002 | US6340668 Administering bone morphogenetic protein-11 (bmp-11) to neuronal cells effective to promote the survival of cells |
| 01/22/2002 | US6340480 Natural composition for the treatment of circulatory conditions |
| 01/22/2002 | US6340469 For prophylaxis of mastitis in cows |
| 01/22/2002 | CA2093794C 1'-aminospiro¬isoquinoline-4(1h),3-pyrrolidine|-1,2',3,5'-(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| 01/17/2002 | WO2002004636A1 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004487A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 01/17/2002 | WO2002004434A1 Colchinol derivatives as vascular damaging agents |
| 01/17/2002 | WO2002004433A2 Melanin concentrating hormone receptor ligands |
| 01/17/2002 | WO2002004006A2 Method for improving the efficacy of artificial insemination of non-human animals |
| 01/17/2002 | WO2002003995A2 Treatment of male sexual dysfunction |
| 01/17/2002 | WO2002003993A2 Use of inhibitors to multidrug resistance protein 5 (mrp5) to enhance intracellular levels of cyclic nucleotides |
| 01/17/2002 | WO2002003986A2 Use of substituted indole compounds for treating breast disorders |
| 01/17/2002 | WO2002003975A2 Combinations of ssri and estrogenic agents |
| 01/17/2002 | WO2002003974A2 Composition comprising folic acid and zinc for improving male fertility |
| 01/17/2002 | WO2002003896A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 01/17/2002 | WO2001044448A3 Human oxidoreductase proteins |
| 01/17/2002 | WO2001034769A3 24 human secreted proteins |
| 01/17/2002 | WO2001026603A3 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | WO2001019817A3 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 01/17/2002 | WO2001016293A3 Dna encoding the human serine protease t |
| 01/17/2002 | WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | US20020007079 Meiosis regulating compounds |
| 01/17/2002 | US20020007066 For treatment/prevention of infection of herpes simplex virus, varicella zoster virus, human cytomegalovirus, or epstein-Barr virus; enzyme inhibitors |
| 01/17/2002 | US20020007065 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 01/17/2002 | US20020006965 Methods and compositions for treating depression and other disorders using optically pure (-)-bupropion |
| 01/17/2002 | US20020006964 Eating disorders; psychological disorders |
| 01/17/2002 | US20020006963 Method of using and compositions comprising (-) sibutramine optionally in combination with other pharmacologically active compounds |
| 01/17/2002 | US20020006957 Method for the synthesis of compounds of formula I and their uses thereof |
| 01/17/2002 | US20020006951 Solid-state form of celecoxib having enhanced bioavailability |
| 01/17/2002 | US20020006933 Method for treating sexual dysfunction with apomorphine at specified plasma concentration levels |
| 01/17/2002 | DE10032132A1 Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung A dermal therapeutic system containing NSAIDs with selective COX-2 inhibition |
| 01/17/2002 | DE10031651A1 Extrakte aus Sophora-Arten, Verfahren zu ihrer Herstellung und Verwendung Extracts of Sophora species, processes for their preparation and use |
| 01/17/2002 | DE10031650A1 Verwendung von Extrakten aus Sophora flavescens oder Sophora subprostrata zur Prophylaxe und Therapie von Krankheitszuständen, die durch einen Mangel an Östrogenen oder durch andere hormonelle Dysregulationen verursacht werden The use of extracts from Sophora flavescens or Sophora subprostrata for the prophylaxis and treatment of pathological conditions caused by estrogen deficiency or by other hormonal dysregulation |
| 01/17/2002 | CA2427066A1 Method for the recovery and application of human defensins as biologically active proteins for the treatment of infections and other diseases |
| 01/17/2002 | CA2416050A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 01/17/2002 | CA2414938A1 Combinations of ssri and estrogenic agents |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2414198A1 Melanin concentrating hormone receptor ligands |
| 01/17/2002 | CA2414112A1 Treatment of male sexual dysfunction |
| 01/17/2002 | CA2411160A1 Colchinol derivatives as vascular damaging agents |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171443A1 Bicyclic heteroaromatic compounds useful as lh agonists |
| 01/16/2002 | EP1171431A1 Compounds, their preparation and use |
| 01/16/2002 | EP1171416A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 01/16/2002 | EP1171135A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | EP1171134A1 Controlled release of sildenafil delivered by sublingual or buccal administration |
| 01/16/2002 | EP1171125A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | EP1171120A1 Methods for alleviating discomfort of a hot flash and compositions therefor |
| 01/16/2002 | EP1171106A1 Treatment of certain cancers associated with weight gain |
| 01/16/2002 | EP0817645B1 Use of gonadotropin in the treatment of benign prostatic hypertrophy |
| 01/16/2002 | EP0721467B1 Use of relaxin as an analgesic and palliative for intractable pain |
| 01/16/2002 | CN1331692A Benzisozazoles and phenones as alpha antagonist |
| 01/16/2002 | CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 01/16/2002 | CN1331597A Use of bisphosphonates for prevention and treatment of infectious processes |